Crossmark

49th Annual Meeting of the Indian Society of Human Genetics and International Conclave on Neurogenetics (ISHG-2025): India’s march towards low-cost rare disease therapeutics

Crossref DOI link: https://doi.org/10.1016/j.lansea.2025.100632

Published Print: 2025-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jothi, Mathivanan https://orcid.org/0000-0003-0268-3610
Thelma, B.K.

Debnath, Monojit
Funding

Funding for this research was provided by:

National Institute of Mental Health and Neurosciences

India Ministry of Science & Technology Department of Science and Technology (SSY/2024/001662)
License Information

Text and Data Mining valid from 2025-08-01

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-06-23
More Information

This article is maintained by: Elsevier

Article Title: 49th Annual Meeting of the Indian Society of Human Genetics and International Conclave on Neurogenetics (ISHG-2025): India’s march towards low-cost rare disease therapeutics

Journal Title: The Lancet Regional Health - Southeast Asia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.lansea.2025.100632

Content Type: simple-article

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Document is current

Any future updates will be listed below